Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Morgan Stanley (NYSE: MS) SEC filings page on Stock Titan brings together the firm’s regulatory disclosures, including current reports on Form 8‑K and other registered securities information. These filings show how Morgan Stanley communicates material events such as quarterly and annual financial results, capital actions, regulatory capital developments and securities offerings.
Form 8‑K filings frequently cover the release of financial information for specific quarters and for the full year, with press releases and financial data supplements filed as exhibits. Other 8‑K reports describe changes in the firm’s Stress Capital Buffer under the Federal Reserve’s supervisory stress testing framework, providing context on Morgan Stanley’s U.S. Basel III Standardized Approach Common Equity Tier 1 capital requirements.
The filings also list the securities registered under Section 12(b) of the Securities Exchange Act of 1934, including common stock, multiple series of non‑cumulative preferred stock represented by depositary shares, and global medium‑term notes issued by Morgan Stanley or Morgan Stanley Finance LLC, with Morgan Stanley acting as guarantor for certain notes. Additional 8‑K filings describe the approval of forms of master notes for global medium‑term notes and related legal opinions and consents.
On Stock Titan, these SEC documents are updated as they are made available on EDGAR. AI‑powered summaries help explain the key points in lengthy filings, so users can quickly see what each 8‑K, 10‑K or 10‑Q addresses without reading every page. Investors can also use this page to monitor registered securities, preferred stock disclosures and other regulatory information related to Morgan Stanley.
Morgan Stanley Finance LLC is offering Buffered PLUS—principal-at-risk structured notes—due 3 August 2028, linked to the Dow Jones Industrial Average (INDU), S&P 500 (SPX) and Russell 2000 (RTY). Each $1,000 note delivers no periodic interest and is an unsecured obligation of MSFL, fully guaranteed by Morgan Stanley.
Pay-off mechanics rely on the worst-performing underlier on the single observation date (31 July 2028):
- If every index closes above its initial level, the investor receives principal + leveraged upside: $1,000 × [1 + (163%–173%) × % gain of the worst performer].
- If any index finishes at or below its initial but at or above 90 % of it, only par ($1,000) is returned.
- If any index closes below 90 % of its initial level, repayment equals principal × (performance factor + 10 %), imposing a 1 : 1 loss beyond the 10 % buffer, subject to a minimum redemption of $100 (10 %).
Key terms
- Issue price: $1,000; estimated value at pricing: ≈ $962.10 (reflects embedded issuance, structuring and hedging costs).
- Leverage factor: to be fixed at 163 %–173 % on 31 July 2025 strike/pricing date.
- Buffer: 10 % downside protection on each index.
- Distribution: sold through fee-based advisory accounts; dealers may earn up to $6.25/note structuring fee; MS &Co. will not receive a sales commission.
- Liquidity: not exchange-listed; secondary market, if any, made solely by MS &Co. at its discretion.
- CUSIP/ISIN: 61778NCZ2 / US61778NCZ24.
Principal risks highlighted by the issuer include:
- Exposure to credit risk of Morgan Stanley/MSFL; notes are unsecured and unsubordinated.
- No periodic income; return depends solely on terminal index performance.
- Concentration in worst-performing index negates diversification; a single index drop below buffer triggers losses.
- Market value likely below issue price after launch owing to embedded costs and use of an internal funding rate advantageous to the issuer.
- Limited liquidity and potential wide bid/offer spreads.
- Tax treatment uncertain; counsel expects prepaid financial contract, but IRS could disagree.
The product targets investors who are bullish to neutral on all three indices over a three-year horizon, can tolerate significant downside risk, and value a modest buffer alongside leveraged participation in capped equity upside.